Do hospice programs allow medical cannabis?

Most hospices have no formal cannabis policy, but support is widespread among staff. A survey of 310 hospice professionals across 40 states found that 91% support medical cannabis for hospice patients and 90% regularly respond to patient questions about cannabis. Fifty percent of hospice physicians have never written a cannabis order, but most will not prohibit use by patients with existing medical cannabis cards.

Is terminal illness a qualifying condition for medical cannabis?

In several states, yes. Nevada, New Mexico, Connecticut, Delaware, Florida, and Minnesota explicitly recognize terminal illness as a qualifying condition for medical cannabis programs. In other states, patients may qualify through specific symptoms such as chronic pain, nausea, or wasting syndrome that commonly accompany terminal diagnoses.

How does cannabis help palliative care patients?

Cannabis is the only antiemetic that also stimulates appetite — a unique advantage for patients experiencing both nausea and cachexia, according to Dr. Donald Abrams of UCSF. NASEM rated the evidence for cannabinoids treating chemotherapy-induced nausea and vomiting as conclusive or substantial. Beyond symptom management, palliative care clinicians report that cannabis helps patients maintain quality of life. As Eloise Theisen at Stanford notes: "In our patients who may have months to a few years to live, still being able to experience joy is really important."

Cannabis in Hospice and Palliative Care

Hospice and palliative-care teams are often more accepting of cannabis. End-of-life pain, appetite, anxiety, and the comfort-care framing that opens conversations.

Hospice Professionals Quietly Support Cannabis

The gap between official policy and actual practice in hospice care is enormous. A survey of 310 hospice professionals across 40 states revealed a field that overwhelmingly supports cannabis access even without formal institutional backing:

91% of hospice professionals support medical cannabis use for hospice patients
90% regularly respond to patient questions about cannabis
Most hospices have no formal cannabis policy
50% of hospice physicians have never written a cannabis order — but most will not prohibit use by patients with existing medical cannabis cards

This pattern — support without formal endorsement — reflects the same federal-state tension that complicates cannabis policy in every healthcare setting. Hospice staff want to help their patients but lack institutional frameworks to do so openly.

Terminal Illness as a Qualifying Condition

Several states explicitly recognize terminal illness as a qualifying condition for medical cannabis programs, removing the need to qualify through a specific diagnosis:

Nevada
New Mexico
Connecticut
Delaware
Florida
Minnesota

In states without a specific terminal illness qualifier, patients may still qualify through symptoms common in end-of-life care: chronic pain, nausea, wasting syndrome, or seizures. Ask your palliative care team or hospice social worker about your state's specific qualifying conditions.

California's Ryan's Law (SB 311, effective January 2022) goes further, requiring hospitals, skilled nursing facilities, and hospice facilities to permit terminally ill patients — defined as those with a prognosis of one year or less — to use medicinal cannabis. Patients or their designees may bring cannabis into the facility. For more on facility policies, see Assisted Living & Long-Term Care.

The Clinical Case for Cannabis in Palliative Care

The evidence base for cannabis in end-of-life symptom management draws on some of the strongest findings in cannabis medicine. Strong evidence

Nausea and Appetite

NASEM rated the evidence for cannabinoids treating chemotherapy-induced nausea and vomiting as conclusive or substantial — its highest grade. Both dronabinol (FDA-approved 1985) and nabilone (FDA-approved 2006) are established antiemetics, positioned by current NCCN and ASCO guidelines as breakthrough or rescue therapy.

As Dr. Donald Abrams, Professor Emeritus of Medicine at UCSF and co-author of the 2024 ASCO Guideline on Cannabis and Cannabinoids in Adults with Cancer, has noted: cannabis is the only antiemetic that also stimulates appetite — a unique advantage for patients experiencing both nausea and cachexia.

Pain

Chronic pain evidence is the most robust in cannabis medicine. A 2025 Annals of Internal Medicine review of 25 RCTs found oral high-THC products reduced pain by approximately 0.78 points on a 0-to-10 scale — statistically significant, clinically modest, but meaningful for patients who have exhausted other options or cannot tolerate opioid side effects.

Quality of Life

Beyond measurable symptom relief, palliative care clinicians report that cannabis helps patients maintain engagement with their remaining time. Eloise Theisen, board-certified Adult-Geriatric Nurse Practitioner at Stanford Medicine's palliative care department — who has treated over 7,000 patients with an average age of 76 — puts it directly:

"In our patients who may have months to a few years to live, still being able to experience joy is really important."

Clinicians Leading Palliative Cannabis Care

Dr. Diana Martins-Welch at Northwell Health has written approximately 2,000 cannabis certifications for palliative care patients since 2017 — one of the highest volumes of any palliative care clinician in the country. Her practice demonstrates that cannabis can be integrated into mainstream palliative care when physicians are willing to engage with the evidence and the certification process.

Eloise Theisen at Stanford, in addition to her direct patient care, co-founded Radicle Health and serves as Chief Nursing Officer of Leaf411 — a free national cannabis-trained nurse hotline that can help palliative patients and their families navigate product selection and dosing questions.

Cancer Care — Evidence for cannabinoids in cancer symptom management
Assisted Living & Long-Term Care — Facility policies and state protections
Caregivers — How family members can help manage cannabis care